United Therapeutics (UTHR) Other Working Capital Changes (2014 - 2026)

United Therapeutics has disclosed Other Working Capital Changes across 13 years of filings, most recently posting $104.1 million for Q2 2026.

• In Q2 2026, Other Working Capital Changes fell 43.55% year-over-year to $104.1 million; the TTM figure through Jun 2026 stood at $108.1 million (up 654.36% YoY), while the FY2025 annual figure was $80.9 million, up 1051.76% from the prior year.
• Other Working Capital Changes came in at $104.1 million for Q2 2026 at United Therapeutics, up from -$27.0 million in the prior quarter.
• In the past five years, Other Working Capital Changes ranged from a high of $184.4 million in Q2 2025 to a low of -$134.5 million in Q1 2025.
• Average Other Working Capital Changes over 5 years is $17.7 million, with a median of -$25.0 million recorded in 2023.
• Year-over-year, Other Working Capital Changes jumped 648.41% in 2022 and plunged 1086.05% in 2024.
• Over 5 years, Other Working Capital Changes stood at $94.3 million in 2022, then slumped by 124.5% to -$23.1 million in 2023, then slipped by 16.88% to -$27.0 million in 2024, then soared by 463.7% to $98.2 million in 2025, then gained by 6.01% to $104.1 million in 2026.
• Per Business Quant data, the three most recent Other Working Capital Changes figures were $104.1 million in Q2 2026, -$27.0 million in Q1 2026, and $98.2 million in Q4 2025.